| Literature DB >> 29617667 |
Michael Seiler1, Shouyong Peng1, Anant A Agrawal1, James Palacino1, Teng Teng1, Ping Zhu1, Peter G Smith1, Silvia Buonamici2, Lihua Yu3.
Abstract
Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematological malignancies, suggesting the importance of RNA splicing in cancer. We analyzed whole-exome sequencing data across 33 tumor types in The Cancer Genome Atlas (TCGA), and we identified 119 splicing factor genes with significant non-silent mutation patterns, including mutation over-representation, recurrent loss of function (tumor suppressor-like), or hotspot mutation profile (oncogene-like). Furthermore, RNA sequencing analysis revealed altered splicing events associated with selected splicing factor mutations. In addition, we were able to identify common gene pathway profiles associated with the presence of these mutations. Our analysis suggests that somatic alteration of genes involved in the RNA-splicing process is common in cancer and may represent an underappreciated hallmark of tumorigenesis.Entities:
Keywords: FUBP1; RBM10; SF3B1; SRSF2; U2AF1; cancer; mutation; splicing
Mesh:
Substances:
Year: 2018 PMID: 29617667 PMCID: PMC5933844 DOI: 10.1016/j.celrep.2018.01.088
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423